values that suppose increased efficacy than often is the circumstance (i.e., the model could deal with the top with the curve as remaining equivalent on the nominal total agonist). At the level of bias analysis (ΔΔlog R ADB-BUTINACA is now a issue of curiosity in forensic toxicolo